nimodipine has been researched along with Embryopathies in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Medical treatment of severe hypertension in pregnancy is required." | 2.41 | Management and monitoring of severe preeclampsia. ( Bolte, AC; Dekker, GA; van Geijn, HP, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolte, AC | 1 |
| van Geijn, HP | 1 |
| Dekker, GA | 1 |
1 review available for nimodipine and Embryopathies
| Article | Year |
|---|---|
Management and monitoring of severe preeclampsia.
Topics: Adrenal Cortex Hormones; Antihypertensive Agents; Blood Pressure Determination; Female; Fetal Diseas | 2001 |